Asthma and chronic obstructive pulmonary disease (COPD) are significant health challenges, with asthma affecting around ...

The study demonstrated that asthma treatment is safe, with no significant side effects compared to past studies of the drug.

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease ...

Benralizamab is a monoclonal antibody which targets specific white blood cells, called eosinophils, to reduce lung ...

The first new treatment for asthma attacks in 50 years has been developed, in a move that is being hailed as ‘game-changing’ ...

For the first time in 50 years, a new treatment has been found to improve care for people experiencing asthma or COPD ...

A UK study has shown that a drug currently used to treat severe asthma could be re-purposed for use in emergency settings, ...

King's College London (KCL) has announced the development of a "game-changer" injection it says is the first new treatment ...

Injection for asthma and COPD attacks shows a 30% reduction in the need for further treatment, outperforming steroid tablets.

More than five million people in the UK suffer from asthma, but a new drug called benralizumab could change the game.

Doctors are hailing a new way to treat serious asthma and chronic obstructive pulmonary disease (COPD) attacks that marks the ...

It is already used as a recurring treatment for severe asthma in low doses. However, the trial found that a single higher ...